Legacy Wealth Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-4,133
Closed -$361K – 366
2025
Q2
$361K Buy
4,133
+93
+2% +$7.29K 0.09% 291
2025
Q1
$276K Sell
4,040
-13
-0.3% -$1.06K 0.08% 308
2024
Q4
$315K Buy
+4,053
New +$300K 0.09% 301

Other funds holding DXCM

Legacy Wealth Asset Management's DXCM Position: Q3 2025 in Review

Legacy Wealth Asset Management sold out of DexCom (DXCM) in Q3 2025, closing a stake of 4,133 shares — an estimated $361K sold.

Legacy Wealth Asset Management first reported a position in DXCM in Q4 2024 and held it in 3 quarters. The position peaked at $361K in Q2 2025. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Legacy Wealth Asset Management reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Legacy Wealth Asset Management sold 4,133 DexCom shares in Q3 2025, an estimated $361K.
  • Legacy Wealth Asset Management first reported a position in DexCom in Q4 2024 and held it in 3 quarters.
  • Legacy Wealth Asset Management's DexCom position peaked at $361K in Q2 2025.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Legacy Wealth Asset Management's 13F filing for Q3 2025, filed 14 Oct 2025.